Escitalopram Treatment of Night Eating Syndrome: a Randomized Controlled Trial.
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2016
At a glance
- Drugs Escitalopram (Primary)
- Indications Eating disorders
- Focus Therapeutic Use
- 27 Jul 2012 Status changed from active, no longer recruiting to completed as reporeted by ClinicalTrials.gov record.
- 05 Oct 2011 Results presented at the 2011 Annual Meeting of the North American Association for the Study of Obesity.
- 21 Sep 2010 Planned end date changed from 1 Sep 2009 to 1 Aug 2010 as reported by ClinicalTrials.gov.